SpyGlass Pharma share price logo

SpyGlass Pharma

NASDAQ: SGP

Small Cap

$28.36

+0.14

(+0.51%)

Live

as on

SpyGlass Pharma Stock Performance

as on October 24, 2026 at 6:23 am IST

  • Day's Low

    Day's High

    $27.53
    $28.70
    downward going graph

    2.93%

    Downside

    1.20%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

SpyGlass Pharma share price movements today

Previous Close
$28.22
Open
$28.07
Volume
249.1K
Market Cap
$926.8M
Day's Low - High
$27.53 - $28.70

SpyGlass Pharma Historical Returns

1 Month Return
+ 0.21 %
3 Month Return
+ 35.15 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

SpyGlass Pharma Stock Fundamentals & Key Indicators

Check SpyGlass Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$926.8M

EPS (TTM)

-1.66

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-16.69

Industry PE ratio

-7.12

PEG Ratio

0.12

EBITDA

-58.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-75.64%

SpyGlass Pharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SpyGlass Pharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$926.8MNA-16.690.00%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Analyst Recommendation on SpyGlass Pharma Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for SpyGlass Pharma. Average target price of $42

SpyGlass Pharma Share Price Target

Get share price movements and forecasts by analysts on SpyGlass Pharma.

Current Price

$28.36

Analyzed by

1 Analysts

High

$42

0

Low

$42

SpyGlass Pharma target price $0, a slight upside of 0% compared to current price of $28.36. According to 1 analysts rating.

Indian Investors' Interest in SpyGlass Pharma Stock

Search interest for SpyGlass Pharma Stock has increased by 61% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:61% versus previous 30 day period

SpyGlass Pharma Quarterly Profit & Loss

All numbers in Millions USD

Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
Gross Profit
-
0
0
0
Operating Income
-11
-13
-15
-21
EBITDA
-10
-12
-13
-21
Interest Expense
-
-
-
-
Depreciation
0
0
0
0
Income Before Tax
-9
-12
-13
-19
Income Tax Expense
-
-
-
-
Net Income
-9
-12
-13
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

SpyGlass Pharma Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
-
Gross Profit
0
Operating Income
-41
EBITDA
-39
Interest Expense
-
Depreciation
0
Income Before Tax
-39
Income Tax Expense
-
Net Income
-39
Net Profit Margin
0.00%

SpyGlass Pharma Quarterly Cash Flow

All numbers in Millions USD

Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-12
-13
-19
Operating Cash Flow
-8
-9
-13
-14
Investing Cash Flow
-12
0
-1
0
Financing Cash Flow
0
0
157
0
Change in Cash
-21
-9
142
-15

SpyGlass Pharma Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-39
Operating Cash Flow
-32
Investing Cash Flow
-11
Financing Cash Flow
124
Change in Cash
80

Global Institutional Holdings in SpyGlass Pharma

Check out the Institutions with significant holdings in SpyGlass Pharma.

Funds
Holdings
Peter Kolchinsky
23.98%
Vanguard
2.10%
James E. Flynn
1.64%
VANGUARD INDEX FUNDS
1.27%
iShares
1.06%

SpyGlass Pharma News & Key Events

    Insights on SpyGlass Pharma

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, SGP stock has moved up by 17.6%

    About SpyGlass Pharma

    SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
    OrganisationSpyGlass Pharma
    Headquarters15326 Alton Parkway, Irvine, CA, 92618, US
    IndustryBiotechnology
    CEOPatrick H. Mooney

    Key Management of SpyGlass Pharma

    Name

    Title

    Dr. Chetan Pujara Ph.D.

    Chief Research & Development Officer

    Ms. Shannon Trevino J.D.

    General Counsel

    Mr. Paul Yoo O.D.

    Senior Vice President of Clinical Development

    Dr. Jean-Frederic Viret Ph.D.

    Chief Financial Officer

    Mr. James Robert Dennewill Jr.

    Chief Operating Officer

    Mr. Mike Pinder

    Vice President of Marketing

    Ms. Rachel Gilette

    Vice President of Human Resources

    Dr. Malik Y. Kahook M.D.

    Co-Founder, President, Chief Medical Officer & Executive Chairman

    Mr. Patrick H. Mooney

    CEO & Director

    Mr. Glenn Sussman

    Co-founder & Chief Technology Advisor

    FAQs

    What is SpyGlass Pharma share price today?

    SpyGlass Pharma share price today is $28.36 as on . SpyGlass Pharma share today touched a day high of $28.70 and a low of $27.53.

    What is the 52 week high and 52 week low for SpyGlass Pharma share?

    SpyGlass Pharma share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . SpyGlass Pharma stock price today i.e. is trending at $28.36,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

    What is SpyGlass Pharma's market capitalisation today?

    SpyGlass Pharma market capitalisation is $0.00T as on .

    How to invest in SpyGlass Pharma Stock (SGP) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for SpyGlass Pharma on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy SpyGlass Pharma Stock (SGP) from India?

    Indian investors can start investing in SpyGlass Pharma (SGP) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.40 in SpyGlass Pharma stock (as per the Rupee-Dollar exchange rate as on ). Based on SpyGlass Pharma share’s latest price of $28.36 as on October 24, 2026 at 12:53 am IST, you will get 0.3526 shares of SpyGlass Pharma. Learn more about fractional shares .